BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 26, 2010
View Archived Issues
New beta-lactamase inhibitor MK-7655 shows promise in preclinical and clinical studies
Read More
Cardium Therapeutics reports new findings on Excellagen in wound healing
Read More
LNPEP gene SNP is associated with outcome of patients with septic shock
Read More
IL-17A-targeted antibody AIN-457 shows promise in psoriasis, rheumatoid arthritis and uveitis
Read More
Linifanib monotherapy is active in phase II NSCLC trial
Read More
HIV vaccine MV1-F4 induces robust immune response in monkeys
Read More
Merck & Co. and Scynexis characterize new efumafungin antifungals
Read More
Merck KGaA presents new E-NPP 2 inhibitors
Read More
Santhera regains full U.S. and Canadian rights to fipamezole from Biovail
Read More
Abbott Cardiovascular Systems claims new HCV polymerase inhibitors
Read More
Presidio Pharmaceuticals discovers new inhibitors of HCV NS5A
Read More
Abbott discloses new cannabinoid CB2 receptor ligands
Read More
FDA approves Warner Chilcott's new oral contraceptive
Read More
NeuroVive and to-BBB to codevelop therapies for stroke and other CNS disorders
Read More
CHMP recommends marketing authorization for MedImmune's FluEnz vaccine
Read More
Cellectis and Kyoto University join forces for stem cell research
Read More
CHMP recommends variation of marketing authorization for Pfizer's Sutent
Read More
CHMP recommends new indication for Bristol-Myers Squibb's Sprycel
Read More
EMA recommends changes in prescribing information for Invirase
Read More
Chugai Pharma files for new indication of Pegasys/Copegus combination therapy
Read More
AZD-9773 enters phase IIb trial in patients with severe sepsis and/or septic shock
Read More
Alkermes' combination therapy for cocaine addiction to advance to phase II
Read More
FDA requests additional information from ViroPharma on Cinryze
Read More
Genmab begins phase III trial of ofatumumab versus rituximab in follicular NHL
Read More
Sanofi-aventis initiates phase III TERACLES trial of teriflunomide in relapsing MS
Read More